ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Sano Genetics Ltd

Sano Genetics Ltd is an active company incorporated on 23 February 2017 with the registered office located in London, Greater London. Sano Genetics Ltd was registered 8 years ago.
Status
Active
Active since incorporation
Company No
10636359
Private limited company
Age
8 years
Incorporated 23 February 2017
Size
Large
Did not meet the 2-out-of-3 criteria for Medium size or smaller.
Confirmation
Submitted
Dated 5 December 2025 (27 days ago)
Next confirmation dated 5 December 2026
Due by 19 December 2026 (11 months remaining)
Last change occurred 15 days ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (9 months remaining)
Contact
Address
3rd Floor 86-90 Paul Street
London
EC2A 4NE
England
Address changed on 1 Sep 2022 (3 years ago)
Previous address was Salisbury House Station Road Cambridge CB1 2LA England
Telephone
07442 821712
Email
Unreported
People
Officers
7
Shareholders
37
Controllers (PSC)
1
Director • British • Lives in UK • Born in Nov 1988
Director • British • Lives in England • Born in Feb 1992
Director • American • Lives in UK • Born in Sep 1991
Director • French • Lives in UK • Born in Mar 1989
Director • British • Lives in England • Born in May 1989
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
21 Chesham Place Limited
Paul Hay Forster is a mutual person.
Active
Robin Ai Limited
Carina Namih is a mutual person.
Active
Multiomic Health Limited
Charlotte Elizabeth Barttelot is a mutual person.
Active
Undo Holdings Ltd
Paul Hay Forster is a mutual person.
Active
Molyon Limited
Carina Namih is a mutual person.
Active
Perihelion Limited
William George Dean Jones is a mutual person.
Active
Brands
Sano Genetics
Sano Genetics is a platform that integrates recruitment, genetic testing, and long-term participant engagement to support precision medicine research.
Financials
Net Assets, Total Assets & Total Liabilities (2018–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£5.05M
Decreased by £5.88M (-54%)
Turnover
Unreported
Same as previous period
Employees
66
Increased by 18 (+38%)
Total Assets
£5.95M
Decreased by £6.04M (-50%)
Total Liabilities
-£594K
Decreased by £11K (-2%)
Net Assets
£5.35M
Decreased by £6.03M (-53%)
Debt Ratio (%)
10%
Increased by 4.94% (+98%)
Latest Activity
Confirmation Submitted
15 Days Ago on 17 Dec 2025
Ms Charlotte Elizabeth Barttelot Details Changed
1 Month Ago on 3 Nov 2025
Mr Paul Anthony Mcnabb Details Changed
1 Month Ago on 3 Nov 2025
Mr Paul Hay Forster Details Changed
1 Month Ago on 3 Nov 2025
Full Accounts Submitted
4 Months Ago on 3 Sep 2025
Confirmation Submitted
1 Year Ago on 19 Dec 2024
Ms Carina Namih Details Changed
1 Year Ago on 4 Dec 2024
Mr Bruce Ferguson Macfarlane Details Changed
1 Year 1 Month Ago on 2 Dec 2024
Ms Charlotte Elizabeth Barttelot Appointed
1 Year 2 Months Ago on 16 Oct 2024
Bruce Ferguson Macfarlane Resigned
1 Year 2 Months Ago on 16 Oct 2024
Get Credit Report
Discover Sano Genetics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Director's details changed for Mr Paul Anthony Mcnabb on 3 November 2025
Submitted on 17 Dec 2025
Director's details changed for Ms Charlotte Elizabeth Barttelot on 3 November 2025
Submitted on 17 Dec 2025
Confirmation statement made on 5 December 2025 with updates
Submitted on 17 Dec 2025
Director's details changed for Mr Paul Hay Forster on 3 November 2025
Submitted on 17 Dec 2025
Statement of capital following an allotment of shares on 9 September 2025
Submitted on 18 Sep 2025
Total exemption full accounts made up to 31 December 2024
Submitted on 3 Sep 2025
Appointment of Ms Charlotte Elizabeth Barttelot as a director on 16 October 2024
Submitted on 29 Jul 2025
Termination of appointment of Bruce Ferguson Macfarlane as a director on 16 October 2024
Submitted on 29 Jul 2025
Statement of capital following an allotment of shares on 4 July 2025
Submitted on 9 Jul 2025
Statement of capital following an allotment of shares on 20 March 2025
Submitted on 2 Apr 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year